Advanced Cost Of Revenue from 2010 to 2024

AMS Stock   212.50  5.50  2.66%   
Advanced Medical's Cost Of Revenue is increasing over the years with slightly volatile fluctuation. Overall, Cost Of Revenue is expected to go to about 58.9 M this year. During the period from 2010 to 2024 Advanced Medical Cost Of Revenue annual values regression line had geometric mean of  32,657,758 and mean square error of 8 T. View All Fundamentals
 
Cost Of Revenue  
First Reported
1998-01-31
Previous Quarter
28.6 M
Current Value
31.1 M
Quarterly Volatility
7.8 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Advanced Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Advanced Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.3 M, Interest Expense of 250.6 K or Total Revenue of 132.5 M, as well as many indicators such as . Advanced financial statements analysis is a perfect complement when working with Advanced Medical Valuation or Volatility modules.
  
This module can also supplement various Advanced Medical Technical models . Check out the analysis of Advanced Medical Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Advanced Stock

Advanced Medical financial ratios help investors to determine whether Advanced Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Advanced with respect to the benefits of owning Advanced Medical security.